UnitedHealth Group (NYSE:UNH) Shares Acquired Rep. Lisa C. McClain

Key Points

• Representative Lisa C. McClain purchased shares of UnitedHealth Group (NYSE:UNH) worth between $1,001 and $15,000 on August 13th, highlighting ongoing interest in the healthcare sector.
• UnitedHealth Group's stock recently traded at $339.57, with significant trading volume and a market cap of $307.54 billion, despite missing quarterly earnings expectations.
• The company declared a quarterly dividend of $2.21 per share, reflecting a dividend yield of 2.6% and reaffirming its commitment to returning value to shareholders.

Representative Lisa C. McClain (R-Michigan) recently bought shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on September 12th, the Representative disclosed that they had bought between $1,001 and $15,000 in UnitedHealth Group stock on August 13th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $50,001 - $100,000 in shares of Taiwan Semiconductor Manufacturing NYSE: TSM on 8/28/2025.
• Purchased $1,001 - $15,000 in shares of ACI Worldwide NASDAQ: ACIW on 8/19/2025.
• Purchased $1,001 - $15,000 in shares of HCA Healthcare NYSE: HCA on 8/19/2025.
• Sold $1,001 - $15,000 in shares of Amedisys NASDAQ: AMED on 8/18/2025.
• Purchased $1,001 - $15,000 in shares of Kite Realty Group Trust NYSE: KRG on 8/13/2025.
• Sold $1,001 - $15,000 in shares of ServiceNow NYSE: NOW on 8/13/2025.
• Purchased $1,001 - $15,000 in shares of JD.com NASDAQ: JD on 8/13/2025.
• Sold $1,001 - $15,000 in shares of Trade Desk NASDAQ: TTD on 8/13/2025.
• Sold $1,001 - $15,000 in shares of US Foods NYSE: USFD on 8/13/2025.
• Purchased $1,001 - $15,000 in shares of Agree Realty NYSE: ADC on 8/13/2025.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded down $8.32 during mid-day trading on Tuesday, hitting $339.57. 12,637,391 shares of the company were exchanged, compared to its average volume of 13,065,526. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a 50 day simple moving average of $292.87 and a 200-day simple moving average of $367.43. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The firm has a market cap of $307.54 billion, a price-to-earnings ratio of 14.71, a price-to-earnings-growth ratio of 2.30 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period in the prior year, the business earned $6.80 earnings per share. UnitedHealth Group's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

Analysts Set New Price Targets

A number of equities research analysts have commented on UNH shares. Cantor Fitzgerald reissued an "overweight" rating and issued a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Bank of America raised their target price on UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a report on Monday, August 18th. Sanford C. Bernstein raised their target price on UnitedHealth Group from $337.00 to $379.00 and gave the company an "outperform" rating in a report on Friday, September 5th. Wells Fargo & Company reduced their target price on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating for the company in a report on Monday, August 4th. Finally, Morgan Stanley lifted their price target on UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a research note on Friday. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $358.95.

Institutional Trading of UnitedHealth Group

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Valeo Financial Advisors LLC grew its holdings in UnitedHealth Group by 45.4% in the 2nd quarter. Valeo Financial Advisors LLC now owns 20,173 shares of the healthcare conglomerate's stock valued at $6,293,000 after buying an additional 6,299 shares during the period. Silicon Valley Capital Partners grew its holdings in UnitedHealth Group by 14.8% in the 2nd quarter. Silicon Valley Capital Partners now owns 4,043 shares of the healthcare conglomerate's stock valued at $1,261,000 after buying an additional 522 shares during the period. WT Wealth Management purchased a new stake in UnitedHealth Group in the 2nd quarter valued at about $2,435,000. NWF Advisory Services Inc. grew its holdings in UnitedHealth Group by 306.6% in the 2nd quarter. NWF Advisory Services Inc. now owns 2,468 shares of the healthcare conglomerate's stock valued at $770,000 after buying an additional 1,861 shares during the period. Finally, Alternative Investment Advisors LLC. purchased a new stake in UnitedHealth Group in the 2nd quarter valued at about $1,260,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.